Drugs News and Research RSS Feed - Drugs News and Research

DHA intake can prevent known trigger of lupus, study finds

DHA intake can prevent known trigger of lupus, study finds

A team of Michigan State University researchers has found that consuming an omega-3 fatty acid called DHA, or docosahexaenoic acid, can stop a known trigger of lupus and potentially other autoimmune disorders. [More]
New approach bolsters protein in blood vessels to protect against cerebral malaria

New approach bolsters protein in blood vessels to protect against cerebral malaria

Boosting a protective protein to stabilize blood vessels weakened by malaria showed improved survival beyond that of antimalarial drugs alone in pre-clinical research. [More]
Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal's brain — and a way to block that protein's action. [More]
Combined treatment using complementary medicine and standard care helps reduce preoperative anxiety

Combined treatment using complementary medicine and standard care helps reduce preoperative anxiety

A new study conducted at the University of Haifa has some complementary things to say about complementary medicine. [More]
HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat. [More]
ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease. [More]
Bioactive compound from neem plant shows promising effects on prostate cancer

Bioactive compound from neem plant shows promising effects on prostate cancer

A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half. [More]
Recycling existing drugs may help fight several types of cancer

Recycling existing drugs may help fight several types of cancer

Researchers at the University of Bergen have discovered that a drug against kidney cancer possibly can fight several types of cancer. [More]
Researchers discover how signals from infectious bacteria get to inflammasome sensors

Researchers discover how signals from infectious bacteria get to inflammasome sensors

Researchers at St. Jude Children's Research Hospital have discovered the way signals from infectious bacteria gain entry into the cytoplasm of host cells to activate disease-fighting inflammasomes. [More]
Alcohol produces same neural and molecular changes as rapid antidepressant drugs

Alcohol produces same neural and molecular changes as rapid antidepressant drugs

Can having a few drinks help people with clinical depression feel better? Yes. At least in terms of biochemistry. [More]
FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. [More]
Penn researchers search twitter for tweets about cardiovascular disease

Penn researchers search twitter for tweets about cardiovascular disease

For years, marketers and other commercial data-miners have been using Twitter's vast database of "tweets" to gauge consumer attitudes and track events. Now medical researchers are getting in on the trend. [More]
Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another. [More]
New study reveals endocrine biological function of brown adipose tissue

New study reveals endocrine biological function of brown adipose tissue

Brown adipose tissue -main organ generating heat in the body- is also an endocrine organ that secretes signaling factors that activate the fat and carbohydrates metabolism. [More]
First generation antibiotics show promise for tuberculosis therapy

First generation antibiotics show promise for tuberculosis therapy

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports. [More]
Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs. [More]
Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Toxins from mold found growing on nuts or corn can weaken the airways' self-clearing mechanisms and immunity, opening the door for respiratory diseases and exacerbating existing ones, suggests a study in Nature Scientific Reports published this month from otolaryngology researchers at the Perelman School of Medicine at the University of Pennsylvania. [More]
Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments. [More]
NTU scientists develop new test kit for rapid detection of inflammation in diabetic patients

NTU scientists develop new test kit for rapid detection of inflammation in diabetic patients

Scientists from Nanyang Technological University, Singapore have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation. [More]
New project clarifies molecular processes involved in hidden HIV reservoir

New project clarifies molecular processes involved in hidden HIV reservoir

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. [More]
Advertisement
Advertisement